News | Magnetic Resonance Imaging (MRI) | May 26, 2020

Gadolinium found in elevated amounts near water treatment plants in Tokyo rivers

Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University


May 26, 2020 — Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonplace.

Modern medicine owes a lot to MRI. Doctors can see tumors, inflammation and hemorrhaging deep inside the human body without the need for invasive surgery; unlike CT scans, patients are also not exposed to any ionizing radiation. Its many benefits have meant that MRI machines are now more wide-spread than ever. For example, in 1995, Japan had 6.12 machines per million residents; in 2017, it had 55.21, the highest number per million in the world.

But it might not be all good news. MRI imaging is often carried out after patients are injected with a contrast agent which makes features inside the body clearer in scans. It contains gadolinium, an originally toxic rare earth element that is rendered safe for medical use by binding it to a chelation agent, making it unreactive. After completing its task, 98% of the compound is expelled from a patient's body within 24 hours in the urine and makes its way through the wastewater system. Common wastewater treatment plants cannot remove it, so it passes directly into the environment, albeit in small quantities. On exposure to UV light, lab experiments have shown that it may transform back into a toxic state. This makes it vital to track how much gadolinium finds its way into the environment.

Thus, a team led by Professor Kazumasa Inoue of Tokyo Metropolitan University set out to measure how much gadolinium was being released into rivers in Tokyo. They took samples from a number of locations along the many major rivers of the city. Correcting for the amounts expected in natural shale, they carried out a broad survey of rare earths using mass spectrometry and found a significant elevation in the amount of gadolinium in the water. Importantly, they noticed large spikes in the amounts depending on proximity to water treatment plants. These findings are in agreement with previous work for samples taken inside a treatment plant on the River Weser, Germany.

It should be remembered that the reason why gadolinium is released in the first place is that a patient's kidneys safely pass it from the body. This means that, for the most part, it is also non-reactive in the environment. But as more MRI machines are installed to cater to an ageing population with more healthcare needs, the research team noted that new public policy and the development of new treatment techniques are vital to mitigating the environmental impact of this well-established, lifesaving medical technology.

For more information: www.tmu.ac.jp/english

Related Content of MRI Gadolinium Safety Concerns

The Debate Over Gadolinium MRI Contrast Toxicity

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI


Related Content

News | Clinical Trials

June 7, 2023 — The U.S. Food and Drug Administration (FDA) has announced the availability of a draft guidance with ...

Time June 07, 2023
arrow
News | Linear Accelerators

June 5, 2023 — UMC Utrecht researchers in the Netherlands are starting two new projects to treat cancer with image ...

Time June 05, 2023
arrow
News | Radiology Imaging

May 19, 2023 — Asymptomatic adults with a high accumulation of fat in their muscles, known as myosteatosis, are at an ...

Time May 19, 2023
arrow
News | Teleradiology

May 17, 2023 — Online workflow systems for off-site radiologists are one reason for health care delays that cost ...

Time May 17, 2023
arrow
News | Contrast Media

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
News | Contrast Media

May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced that ...

Time May 15, 2023
arrow
News | Radiation Therapy

May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto ...

Time May 15, 2023
arrow
News | Artificial Intelligence

May 8, 2023 — Artificial intelligence and machine learning (AI/ML) technologies are constantly finding new applications ...

Time May 08, 2023
arrow
News | Mammography

May 5, 2023 — The American College of Radiology (ACR), Breast Cancer Research Foundation (BCRF) and GE HealthCare ...

Time May 05, 2023
arrow
News | Computed Tomography (CT)

May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high ...

Time May 05, 2023
arrow
Subscribe Now